← Evidence map

ArticleTheranostics2020

LncRNA-SLC16A1-AS1 induces metabolic reprogramming during Bladder Cancer progression as target and co-activator of E2F1.

Stella Logotheti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

66 papers cite itlatest 60 shown

2020
…
2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 32863950